最新情報 米国臨床腫瘍学会発表要旨 RM-1929 photo-immunotherapy in patients with recurrent head and neck cancer: Results of a multicenter phase 2a open-label clinical trial. http://abstracts.asco.org/214/AbstView_214_229095.html0003がんと闘う名無しさん2018/06/23(土) 02:09:58.94ID:NgBtUGCz 内容